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Abstract: Brucella infections in wildlife have gained a lot of interest from the scientific community
and different stakeholders. These interests are often different and sometimes conflicting. As a result,
different management perspectives and aims have been implemented (One Health, public health,
veterinary public health, maintenance of a brucellosis free status in livestock, sustainable wildlife
harvesting by hunters, wildlife and environmental health). When addressing Brucella infection in
wildlife, the most important features of Brucella infection should be considered and the following
questions need to be answered: (1) Is Brucella infection a result of a spillover from livestock or
is it a sustainable infection in one or more wildlife host species? (2) Did the epidemiological
situation of Brucella infection in wildlife change over time and, if so, what are the main drivers
of change and does it impact the wildlife population dynamics? (3) Does Brucella infection in wildlife
represent a reservoir of Brucella strains for livestock? (4) Is Brucella infection in wildlife of zoonotic
concern? These questions point to the fundamental biological question of how animal (domestic
and wildlife)/Brucella spp. partnerships are established. Will we be able to decipher an evolutionary
trajectory through a livestock-to-wildlife “host jump”? Whole genome sequencing and new “omics”
techniques will help in deciphering the molecular basis of Brucella host preference and open new
avenues in brucellosis management aimed at preventing opportunities for Brucella host jumps.
Keywords: Brucella infection; wildlife/livestock/human interface; Brucella/host partnerships;
host jump
1. Background: Different Perspectives of Brucellosis
1.1. The One Health Perspective
The One Health (OH) concept gained momentum by putting the emphasis on emerging zoonoses,
particularly viral emerging zoonoses, with pandemic potential such as SARS and influenza in wildlife,
livestock and at the wildlife/livestock/human interface [1]. Brucellosis is a bacterial disease, usually
enzootic, that, in certain epidemiological situations, may show an increasing prevalence in livestock
and/or wildlife, potentially leading to an increased incidence in human cases at a local or regional
level. We understand intuitively that measures needed to mitigate the burden of zoonoses with
pandemic potential, on one hand, and enzootic diseases like brucellosis, on the other hand, must be
different [2]. Likewise, the degree of integration of different disciplines and sectors (public health,
veterinary (public) health, environment health) will vary too. Indeed, in the case of an emerging
zoonosis with pandemic potential, early detection in livestock and wildlife reservoirs is crucial to
avoid transmission to humans leading to a pandemic, whereas from the public health perspective,
early detection in the animal reservoir is of little relevance for brucellosis, which, if transmitted to
Vet. Sci. 2018, 5, 81; doi:10.3390/vetsci5030081 www.mdpi.com/journal/vetsci
Vet. Sci. 2018, 5, 81 2 of 9
humans, does not spread between humans (with the exception of occasional in utero transmission)
and is thus of no pandemic concern.
1.2. The Disease Control/Eradication Perspective
In some developed countries, brucellosis in livestock (bovines, small ruminants, and pigs) has
been eradicated and has thus become exotic or alien. From an economic point of view, it is of the utmost
importance to reach and to keep a “brucellosis-free” status in livestock to be able to trade living animals
freely without having to test animals for brucellosis before movement, which is extremely costly [3].
In this perspective, the presence of a reservoir of Brucella spp. in wildlife is, under certain conditions,
considered a threat. Indeed, the transmission of Brucella spp. to livestock (“spillback” infection) may
jeopardize the brucellosis-free status in livestock with disastrous economic consequences [4]. In this
context, the management of brucellosis is done with the primary goal of preventing transmission from
wildlife to livestock, and this is not done in an OH perspective. This is highlighted by Brucella abortus
infection in cattle, bison (Bison bison), and elk (Cervus canadensis) in the Greater Yellowstone Area
(GYA) in the USA [4]. Since all states in the USA are now designated “brucellosis-free”, the Designated
Surveillance Area of Wyoming, Idaho, and Montana is essentially in a perpetual “Class A” status
requiring that all sexually intact cattle leaving the area must be tested, vaccinated, and managed under
other specific procedures and requirements [4]. Conversely, in Europe, there is a huge reservoir of
Brucella suis biovar 2 in wild boar (Sus scrofa) that is not considered a threat for the pig industry and
only of concern for outdoor reared pigs, a marginal production system [5]. As a result, there is no
specific brucellosis management of brucellosis in wild boar, even more so given that B. suis biovar 2 is
of limited zoonotic concern [6]. Recently, a focus of Brucella melitensis infection has been identified in a
population of Alpine ibex (Capra ibex) in the Bargy area (French Alps), in a region where brucellosis
was eradicated in livestock more than two decades ago. Interestingly, brucellosis in Alpine ibex has
been identified after a human case associated with the consumption of cheese made from raw cow
milk had been diagnosed. The tracing back to the B. melitensis-infected cattle herd and the molecular
typing of Brucella isolates suggested that the bovine B. melitensis infection could have originated from
the Alpine ibex population [7]. However, from a veterinary and public health perspective, the risk of
spillback to livestock and from there to humans is considered very low [8].
1.3. The Public Health Perspective
In low- and middle-income countries (LMICs), brucellosis in livestock is to a large extent still
enzootic and it is in these countries that human patients suffer the most important burden of zoonotic
brucellosis. Out of the 500,000 new human brucellosis cases occurring every year, the vast majority is
occurring in LMICs and is connected to contact with infected livestock and consumption of infected
animal products [9]. In sub-Saharan Africa, no proof of direct transmission of Brucella spp. form
wildlife to humans has been reported in the international scientific literature, although transmission
from preparing and consuming buffalo (Syncerus caffer) bushmeat has been suggested [10]. A recent
systematic review on wildlife brucellosis in Africa highlights that buffalo is by far the wildlife species
in which brucellosis has been most frequently reported, mainly through serological inquiries, and only
rarely by isolation of Brucella spp. [11]. There is therefore a need to isolate, identify, and characterize
Brucella strains from buffalo and human patients to be able to demonstrate direct transmission from
wildlife to humans. This would alert public health officials to human Brucella infections arising from
the consumption of bushmeat.
Special attention needs to be given to Brucella infections in the Arctic. Indigenous people have lived
in the Arctic for thousands of years. Nowadays, the region represents one of the least populated areas
in the world, with sparse nomadic communities and very few large cities and towns. Residents of the
Arctic include several indigenous groups as well as more recent arrivals from more southern latitudes.
In total, only about 4 million people live in the Arctic, and in most countries indigenous people make up
a minority (about 10%) of the Arctic population. Once completely nomadic, indigenous people are now
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mostly sedentary or seminomadic, practicing traditional methods of hunting, fishing, reindeer herding,
gathering wild plants for food, and indigenous arts and crafts. The intergovernmental Arctic Council
(https://arctic-council.org/index.php/en/) promotes sustainable development in the Arctic region,
including economic and social development, improved health conditions, and cultural well-being
for Arctic people. Very little livestock farming occurs in the Arctic, and thus the origin of human
brucellosis is to be found in Arctic wildlife. Up to this day, only B. suis biovar 4 infection originating in
semi-domesticated reindeer (Rangifer tarandus) has been diagnosed in human patients [12], with no
known human case of Brucella infection originating from other terrestrial wildlife species or marine
mammals [13].
2. Infection Biology and Serological Diagnosis of Brucellosis
As for any type of zoonosis at the wildlife/livestock/human interface, there is a need to decipher
and understand the infection biology of Brucella spp., the ecology of Brucella infection in multi-host
complex systems, and the drivers of change in the epidemiology of Brucella infection to be able to
design and implement valid mitigation strategies. It is important to acknowledge that such strategies
have different aims and will thus be implemented in different perspectives, including or not OH.
These different aims (OH, public health, veterinary public health, maintenance of a brucellosis-free
status in livestock, sustainable wildlife harvesting by hunters, wildlife and environmental health) must
be clearly highlighted beforehand to allow stakeholders to take ownership, avoiding discipline-specific
“silos” that only rarely interact with one another and are likely to (at best) only partially address the
concerns of some interested groups [14].
Before addressing transmission of Brucella spp. at the wildlife/livestock/human interface, it is
worth being reminded of some of the most important features of Brucella infection biology and
diagnostics [15,16].
Brucella exposure may or may not be followed by Brucella infection. Brucella infection may or may
not induce a protracted immune response resulting in local or general pathology and in the production
of antibodies, detectable by serology. Pathology may or may not result in clinical signs. When Brucella
infection results in clinical signs, it is named brucellosis. Brucellosis is characterized by acute infections
(e.g., abortion) and chronic infections (e.g., hygromas).
Animals infected with Brucella spp. are only infectious to congeners, other animal host species
and humans at limited periods of time. Typically, aborting females are a source of bacteria through
aborted fetuses, vaginal discharges (lochia), and milk. Males may intermittently excrete Brucella spp.
in semen (venereal transmission) and have not been shown to be a significant source of infection except
for Brucella ovis and to a lesser extent Brucella suis. In other words, Brucella-infected animals are not
always infectious and thus transmission cannot occur outside a time window when animals excrete
Brucella spp.
Besides being 100% sensitive and 100% specific, an ideal serological test should make it possible
to differentiate infectious animals from infected or exposed ones. Unfortunately, such a test does
not exist, and the only diagnosis of certainty is bacterial isolation or DNA detection of Brucella
spp. Brucellosis serology has other drawbacks, among which is the impossibility to ascribe which
Brucella species induced antibodies in the host and the impossibility (per definition) to detect “latent”
infection, defined as a seronegative Brucella-infected animal. Latent infection has been well studied
in bovines, where up to 10% of calves born to B. abortus-infected heifers remain seronegative [17].
Most latently infected female calves will abort at their first pregnancy. Latent infection has not been
studied in wildlife brucellosis and thus brucellosis seroprevalence studies in wildlife may be biased
and possibly misleading.
3. Transmission of Brucella spp. at the Wildlife/Livestock/Human Interface
The aim of this manuscript is to highlight some of the questions that need to be addressed when
studying Brucella infections in wildlife and at the wildlife/livestock/human interface.
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3.1. Is Brucella Infection a Result of a Spillover from Livestock or Is It a Sustainable Infection in One or More
Wildlife Host Species?
One of the hallmarks of Brucella infection is host specificity or preference, given that specificity
is not absolute. For livestock species, it is well recognized that B. melitensis infects primary members
of the family Bovidae, subfamily Caprinae, like sheep (Ovis aries) and goats (Capra aegagrus hircus).
These host species are “reservoir” host species, i.e., the host in which the infectious agent multiplies
and/or develops, and on which the agent depends for survival in nature. However, members of the
family Bovidae, subfamily Bovinae, like cattle (Bos taurus), and members of the family Camelidae,
like dromedary camels (Camelus dromedaries), can also be infected and show typical brucellosis clinical
signs like abortion. Importantly, B. melitensis infection is always reported in cattle and camels having
had contact with B. melitensis-infected sheep and goats. This suggests that under traditional husbandry
systems, cattle and camels may not be B. melitensis sustainable hosts, i.e., able to maintain the infection
within their species without any external source of bacteria from a reservoir host species.
There is ample information in the literature highlighting that different wildlife species have been
exposed to Brucella spp. However, very few studies address the sustainability of Brucella infection in
wildlife. Those Brucella infections that are recognized as sustainable in wildlife are the following ones:
Brucella abortus in buffalo and bison; B. melitensis in Alpine ibex; Brucella suis biovar 2 in wild boar and
European hare (Lepus europeaus); Brucella suis biovar 4 in reindeer (Rangifer tarandus); Brucella ceti in
cetaceans. Recently, new species of Brucella have been described in different host species, i.e., Brucella
microti in voles and red fox (Vulpes vulpes); Brucella vulpis in red fox; Brucella inopinata in frogs and
humans; and Brucella papionis in baboons (Papio spp.) [18]. However, it is still not known if these hosts
are the (sole) preferential hosts. Brucella suis biovar 1 infection in feral pigs in the USA and Australia
will not be discussed in this manuscript, since feral pigs are pigs living in the wild but which have
descended from escaped or released domesticated individuals, some of which were infected with
B. suis biovar 1.
One of the most intriguing features of brucellosis in wildlife concerns B. abortus infection in
members of the family Cervidae, subfamily Cervinae, i.e., red deer (Cervus elaphus) in Europe and elk
(Cervus canadensis) in North America, now classified as two different species.
There are only anecdotal reports on B. abortus infection in red deer in Europe, even at the time
B. abortus was enzootic in cattle populations throughout the continent, suggesting that red deer are
not able to sustain B. abortus infection, under management practices implemented in Europe [19].
The situation is dramatically different in some elk populations in North America, as highlighted in the
GYA. Indeed, whole genome sequencing of B. abortus isolates collected from 1985 to 2013 in cattle, elk,
and bison across the GYA suggest that Brucella infection was introduced into GYA bison and elk on at
least five separate occasions, presumably from cattle. One of these five clades is mainly associated
with bison within Yellowstone [20]. However, these estimates only provide the number of transition
events for the currently available isolates rather than estimating actual transmission rates per unit
time in different locations and thus the amount of cross-species transmissions that occurs between
elk and bison is currently unknown [20]. Nevertheless, this suggests that there may be significant
differences in host preference among different B. abortus clades. Likewise, it is important to recognize
that there has been limited progress in understanding Brucella host preference and genetic resistance
to brucellosis [21]. So far, the identified variations only partially explain the differences in virulence
among Brucella species and their specificity for certain host species [22].
The B. abortus isolates from many of the unfed elk in Montana and Wyoming, however, originated
from the Wyoming feedgrounds instead of Yellowstone bison. Two different clades were able to move
from Wyoming feedgrounds to western Montana, potentially in the 1990s to early 2000s, followed by
subsequent local transmission rather than repeated invasions from the feedgrounds, suggesting that
elk can maintain the infection locally after those introductions [20].
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3.2. Did the Epidemiological Situation of Brucella Infection in Wildlife Change Over Time and, If So, What Are
the Main Drivers of Change and Does It Impact the Population Dynamics?
In October 2017, a technical report entitled “Revisiting Brucellosis in the Greater Yellow Stone
Area” was published by the US National Academies Press [4]. In its preface, the following is mentioned:
“This report examines the changing dynamic of brucellosis in the GYA, providing a comprehensive
update of what is new since the 1998 National Research Council report “Brucellosis in the Greater
Yellowstone Area” and exploring various options for addressing the challenge of brucellosis disease
management. Much has changed in the 19 years since the previous report. There is now clear evidence
that transmission of B. abortus to domestic livestock in the GYA has come from infected elk, not bison,
posing greater challenges for control of transmission to domestic species”.
The GYA is estimated to support roughly 450,000 cattle that have the potential to come into contact
with approximately 125,000 elk and 3000 to 6000 bison residing in the GYA. Since 2000, 27 outbreaks of
B. abortus infection in cattle and domestic bison have been detected in the GYA, and all these outbreaks
have originated from spillback B. abortus infection from elk, as demonstrated by molecular tools [20].
Why did these changes occur at this point in time and what are the drivers of such dramatic changes?
Ecological changes within the GYA since 1998 have shifted the dynamics of wildlife populations.
For instance, “the reintroduction of wolves and increases in grizzly bear numbers have impacted the
density and distribution of elk, and the rising number of private landowners has changed land use
around national parks, with private lands increasingly serving as refugia for elk from hunting” [4].
The reader is referred to this publication for information related to management options, which will
not be discussed in this manuscript.
Importantly, it is not known if these ecological changes were sufficient to allow some B. abortus
clades to overcome host species barriers, and such changes do not explain how unfed elk populations
can maintain brucellosis at seroprevalence levels like those of elk on the supplemental feedgrounds in
Wyoming [20]. While the possibility of a host jump of a B. abortus clade to GYA elk is an appealing
hypothesis, it still needs to be tested.
Although B. abortus induces abortion events and has the potential to have significant impacts on
individual animals (such as testicular abscesses, retained placentas, arthritis, death of neonates), it is
not generally considered to be a direct threat to the sustainability of either elk or bison populations [4].
The same conclusions have been obtained in B. abortus-infected buffalo in Kruger National Park, South
Africa [23].
3.3. Does Brucella Infection in Wildlife Represent a Reservoir of Brucella Strains for Livestock?
Different answers are given to this question, as highlighted by the transmission of B. abortus in
the GYA between elk, bison, and cattle. Interestingly, since 2000, only spillbacks from elk have been
reported. No spillback from bison has been documented, notwithstanding that the prevalence in bison
is comparable to the prevalence before 2000, highlighting that the spatial and temporal separation
management between cattle and bison (still considered a threat) is a sound management practice in
the GYA.
In Europe, only a few cases of B. suis biovar 2 transmission from wild boar to outdoor-reared
pigs and bovines have been documented. In the latter case, there is clear evidence that bovines cannot
sustain B. suis biovar 2 infection [24].
In Kenya, a recent serological inquiry performed on cattle from three villages at varying distances
from the Maasai Mara National Reserve, home of large populations of wild ruminants such as buffaloes
and wildebeest (Connochaetes taurinus), suggested that closer contact with wildlife may increase the
transmission of Brucella spp. between livestock and wildlife [25]. Comparable results were obtained at
selected livestock/wildlife interface areas of the Gonarezhou National Park, Zimbabwe [26]. A recent
study performed in South Africa in a rural community established at the border of Kruger National
Park (home of more than 35,000 buffaloes with an estimated brucellosis seroprevalence of 10%)
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suggested that the close proximity of brucellosis-infected buffalo was not a threat to domestic animals
in a controlled setting with vaccination, fencing, and movement control [27].
These examples highlight that every single situation is a study case in its own right, and that no
general unambiguous answer should be given.
3.4. Is Brucella Infection in Wildlife of Zoonotic Concern?
It is worth noting that, to date, there is no documented report on the direct transmission of
B. abortus from elk to human in the GYA in the scientific literature. Although the Yellowstone Park
service raises awareness about the risk for people in the GYA (https://www.nps.gov/yell/learn/
nature/brucellosis.htm), the US Center for Disease Control and Prevention only mentions hunting feral
pigs (infected with B. suis biovar 1) as a zoonotic risk (https://www.cdc.gov/brucellosis/exposure/
hunters.html).
The best way to answer this question unambiguously is to analyze the situation in the Arctic,
where livestock farming is almost nonexistent. In the Arctic, B. suis biovar 4 infection is found
in reindeer/caribou, and Brucella ceti and Brucella pinnipedialis infections are found primarily in
different cetacean and seal species, respectively. Human B. suis biovar 4 infections originating in
semi-domesticated reindeer have been reported in indigenous people in Canada, Alaska, and Russia.
In North America, the average number of cases is one per year [12]. The situation is globally comparable
in Russia, with an exception of Yakutia, in the Far East, where the percent of infection remains high
(4.8–5.6%) among reindeer breeders [28].
Although Brucella infection is widely spread in cetaceans and pinnipeds in the Arctic, does this
mean that there is a zoonotic risk? Brucella pinnipedialis Strain Type 27 (ST27) is the only marine mammal
Brucella strain that has been documented in natural infection cases in humans [29,30]. To date, less than
five cases have been reported worldwide and all of them occurred in the Southern hemisphere [31].
Some of these cases were not related to contact with marine mammals or consumption of their products,
suggesting that the infection may have been acquired through the consumption of seafood [29].
Interestingly, it has been documented that true seals are likely Brucella spillover hosts [32,33], acquiring
the infection from fish [34] or lungworms [35], while the infection biology in eared seals is not
known [13]. In the Arctic, ST27 has, to date, not been isolated from any marine mammal species.
Although upholding a traditional life style may represent a risk for Brucella infection in indigenous
people in the Arctic, the risk is very low for B. suis biovar 4 (with the exception of Yakutia, Russia) and
negligible for B. pinnipedialis ST27. Under such circumstances, the issue becomes how to communicate
brucellosis risk while still promoting the health benefits of a traditional life style. In this perspective,
the Alaska Native Tribal Health Consortium has published information about brucellosis, addressing
frequently asked questions by indigenous people (https://anthc.org/wp-content/uploads/2016/01/
CCH-Bulletin-No-6-Brucellosis.pdf).
4. Conclusions
Regardless of health and management perspectives, the aforementioned questions and answers
point to the fundamental biological question of how animal (domestic and wildlife)/Brucella spp.
partnerships are established. In 2015, it was reported that the evolutionary trajectory of the common
rabbit clone of Staphylococcus aureus evolved through a likely human-to-rabbit “host jump” some
40 years ago and that only a single naturally occurring nucleotide mutation was required and sufficient
to convert a human-specific S. aureus strain into one that could infect rabbits [36]. Such a single
naturally occurring mutation associated with a bacterial host-switching event represents a paradigm
shift in the understanding of the minimal adaptations required for a bacterium to overcome species
barriers and establish itself in new host populations.
The capacity of microbial pathogens to alter their host tropism in distinct host species populations
is a global public and veterinary health concern. Ecosystems are complex multi-host systems.
A pathogen host jump in such systems will occur after selection of naturally occurring mutants
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by the multiplication of contacts, with only a few of them being infectious. The multiplication of
contacts at the wildlife/livestock/human interface resulting in emerging diseases is mainly the result
of anthropological-driven ecological changes [37]. In the case of the GYA, it is now accepted that
feedgrounds have played a major role in the changes occurring in the epidemiology of brucellosis at
the elk/bison/bovine interface [4]. Following such ecological changes, we hypothesize that nucleotide
mutation events occurring naturally in Brucella strains may have been selected by the multiplication of
exposure of elk to B. abortus strains originating in cattle, resulting in a host-switch converting a few
bovine B. abortus-adapted strains to strains that could sustain B. abortus infection in elk. Such a
hypothesis needs to be tested. Recently, it has been demonstrated that Mycoplama gallisepticum
emergence in house finches (Haemorhous mexicanus) requires more than direct contact with domestic
poultry. Indeed, mutations arising in its original poultry host are necessary for successful pathogen
emergence in the novel finch host [38]. Whole genomic sequencing and analysis by new “omics”
techniques of B. abortus isolates from different host species before and after the year 2000 may highlight
whether B. abortus in the GYA evolved through a bovine-to-elk host jump. Such studies will help
in deciphering the molecular basis of Brucella host preference and open new avenues in brucellosis
management aimed at preventing opportunities for Brucella host jumps.
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